Bill & Melinda Gates Foundation grants USD 128m to Pfizer for RSV and GBS vaccines
Pfizer has received funding to bring vaccines to lower-income countries, targeting infections that are potentially deadly for infants.
by mikkel aabenhus hemmingsen, translated by daniel pedersen
The Bill & Melinda Gates Foundation is sending USD 128m to Pfizer for the purpose of supporting the development of vaccines against the respiratory syncytial virus, RSV, and group B streptococcus (GBS), a press release announces.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.